P

Inventor

POUDEL YAM B

US24 patents
⚠️ This page may combine multiple inventors who share the name “POUDEL YAM B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

21 patents
US10494370B2Dec 3, 2019

Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO15 citations94
US10487084B2Nov 26, 2019

Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO16 citations94
US10472361B2Nov 12, 2019

Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO16 citations94
US10508115B2Dec 17, 2019

Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO13 citations92
US10457681B2Oct 29, 2019

Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO15 citations84
US11554120B2Jan 17, 2023

1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor

BRISTOL MYERS SQUIBB CO4 citations74
US11400094B2Aug 2, 2022

2H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor

BRISTOL MYERS SQUIBB CO4 citations73
US10898578B2Jan 26, 2021

Modified self-immolating moieties for use in prodrugs and conjugates and methods of using and making

BRISTOL MYERS SQUIBB CO4 citations73
US11911483B2Feb 27, 2024

Modified self-immolating moieties for use in prodrugs and conjugates and methods of using and making

BRISTOL MYERS SQUIBB CO0 citations62
US10941145B2Mar 9, 2021

Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO0 citations62
US10927114B2Feb 23, 2021

Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO0 citations62
US10919895B2Feb 16, 2021

Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO0 citations62
US10913741B2Feb 9, 2021

Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO0 citations62
US10981914B2Apr 20, 2021

Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO0 citations61
US12485123B2Dec 2, 2025

1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists

BRISTOL MYERS SQUIBB CO0 citations52
US10793569B2Oct 6, 2020

Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO0 citations52
US10723736B2Jul 28, 2020

Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO0 citations52
US10711003B2Jul 14, 2020

Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO0 citations52
US10696676B2Jun 30, 2020

Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO0 citations52
US10689382B2Jun 23, 2020

Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor

BRISTOL MYERS SQUIBB CO0 citations52
US11485741B2Nov 1, 2022

Macrocyclic toll-like receptor 7 (TLR7) agonists

BRISTOL MYERS SQUIBB CO0 citations51

UNIV RICE WILLIAM M

3 patents